Table 1. Comparison of demographics of patients with diabetes and non-diabetes who tested positive for SARS-CoV-2.
| Characteristic | Total n = 737 | Diabetes n = 381 (51.70%) | Non-Diabetes n = 356 (48.30%) | p Value |
|---|---|---|---|---|
| Age—mean ± SD | 65 ± 17 | 68 ± 12 | 62 ± 20 | <0.0001 |
| < 45 | 69 (9.47%) | 11 (2.93%) | 58 (16.43%) | |
| 45–64 | 233 (31.69%) | 121 (32.18%) | 112 (31.73%) | |
| >65 | 427 (58.57%) | 253 (64.89%) | 183 (51.84%) | |
| Male | 367 (49.80%) | 191 (50.13%) | 176 (49.44%) | 0.8508 |
| Race | 0.5071 | |||
| Black | 654 (88.74%) | 342 (89.76%) | 312 (87.64%) | |
| W | 45 (6.11%) | 23 (6.04%) | 22 (6.18%) | |
| Asian | 4 (0.54%) | 1 (0.26%) | 3 (0.84%) | |
| American Indian—Alaska Native | 1 (0.14%) | 1 (0.26%) | 0 | |
| Undisclosed | 33 (4.48%) | 14 (3.67%) | 19 (5.34%) | |
| Comorbidities | ||||
| Asthma | 42 (5.70%) | 24 (6.30%) | 18 (5.06%) | 0.467 |
| Cancer | 34 (4.61%) | 15 (3.94%) | 19 (5.34%) | 0.3652 |
| CAD | 95 (12.89%) | 63 (16.54%) | 32 (8.99%) | 0.0022 |
| CHF | 56 (7.60%) | 39 (10.24%) | 17 (4.78%) | 0.0052 |
| COPD | 25 (3.39%) | 15 (3.94%) | 10 (2.81%) | 0.3979 |
| CKD | 99 (13.43%) | 66 (17.32%) | 33 (9.27%) | 0.0014 |
| ESRD | 87 (11.80%) | 57 (14.96%) | 30 (8.43%) | 0.006 |
| HTN | 498 (67.57%) | 301 (79.00%) | 197 (55.34%) | <0.0001 |
| Obesity (BMI>30) | 107 (14.52%) | 75 (19.69%) | 32 (8.99%) | <0.0001 |
| Hyperlipidemia | 194 (26.32%) | 129 (33.86%) | 65 (18.26%) | <0.0001 |
| Outcomes | <0.0001 | |||
| Discharged Home | 415 (56.31%) | 181 (47.51%) | 234 (65.73%) | |
| Transferred to Tertiary Care center | 78 (10.58%) | 53 (13.91%) | 25 (7.02%) | |
| Mortality rate | 244 (33.11%) | 147 (38.58%) | 97 (27.25%) |
CAD = Coronary Artery Disease; CHF = Congestive Heart Failure; COPD = Chronic Obstructive Pulmonary Disease; CKD = Chronic Kidney Disease; ESRD = End Stage Renal disease; HTN = Hypertension; BMI = Body Mass Index.